Compositional Analysis of Glycosaminoglycans in Different Lung Cancer Types-A Pilot Study

Area of Science:

• Biochemistry
• Oncology
• Molecular Biology

Background:

• Lung cancer is a leading cause of cancer diagnoses globally.
• Understanding molecular alterations in lung cancer is crucial for developing novel therapeutics and early detection markers.
• Glycosaminoglycans (GAGs) are implicated in tumor microenvironment signaling pathways.

Purpose of the Study:

• To quantify and characterize chondroitin sulfate (CS) and heparan sulfate (HS) in various lung cancer types and adjacent normal tissues.
• To investigate the role of GAGs in lung cancer development and progression.

Main Methods:

• Analysis of GAG disaccharides using High-Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS).
• On-surface lyase digestion of GAGs from formalin-fixed paraffin-embedded human lung tissue.
• Comparison of GAG profiles between tumor tissues and adjacent normal tissues across different lung cancer subtypes.

Main Results:

• Significant alterations in chondroitin sulfate quantity and sulfation patterns were observed in lung cancer tissues compared to normal tissues.
• Total chondroitin sulfate amount was elevated in tumor tissues.
• Differences in the degree of sulfation and the relative proportions of CS disaccharides were noted between lung cancer types and normal tissues.
• The 6-O-/4-O-sulfation ratio of chondroitin sulfate varied significantly among different lung cancer types.

Conclusions:

• Chondroitin sulfate exhibits distinct quantitative and qualitative changes in lung cancer.
• Sulfation patterns of chondroitin sulfate may serve as potential biomarkers for lung cancer classification and progression.
• Further research into chondroitin sulfate chains and their biosynthesis is warranted for lung cancer investigation.